Delivering Integrated Care and Cost Management
The IHTC works collaboratively with payors to optimize care. We ensure that the patients and families we serve have access to care and therapies, thereby helping to contain costs and reduce both bleeding events and utilization of resources.
The IHTC Pharmacy’s ability to purchase clotting factor through the Public Health Service 340B discount program and our overall pricing structure benefit payors and patients by dispensing clotting factor at significantly reduced prices.
Sickle Cell Disease Resources
The IHTC is involved a variety of research studies to better understand the complications of sickle cell disease. It is our hope that this research will allow the medical community at large to develop treatments to prevent or minimize complications, prolong and improve the quality of life for those with sickle cell disease. Through the IHTC, patients have access to national multicenter studies.
If you are interested in participating in a research study, please let a member of our healthcare team know.
IHTC currently has no active research studies enrolling patients. Please check the website often, we will be enrolling patients for future studies soon!
Links to: